Paul Workman

Share on twitter
Share on facebook
Share on linkedin
Share on social media
Healthy Lives
On site

Paul Workman

The Institute of Cancer Research, London

Professor Workman is a passionate advocate of personalised molecular medicine and is an enthusiastic practitioner of multidisciplinary cancer drug discovery and development approaches to ‘drugging the cancer genome’. He also conceptualised the ‘Pharmacological Audit Trail’ approach.As well as establishing and successfully leading drug discovery project teams yielding clinical candidates, Professor Workman’s personal and collaborative research utilises molecular pharmacology and chemical biology approaches, including high-throughput and genome-wide as well as hypothesis-driven strategies, to interrogate cancer biology, identify and validate new drug targets, discover and develop chemical tools and drugs acting on these targets, identify predictive and mechanism of action biomarkers, and elucidate mechanisms of drug sensitivity of resistance.
Share on twitter
Share on facebook
Share on linkedin
Share on social media

Agenda

Tuesday, July 12 | 
12:30
 — 13:00
Probing and drugging the cancer genome to overcome tumour evolution and therapy resistance
The Institute of Cancer Research

Cookies

This website uses cookies to give you the best, most relevant experience. Using this website means you’re OK with this. Learn more in our cookie policy.